Cardiomyopathy Genetic tests in Dubai & UAE

Compare available Cardiomyopathy Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

1,100.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Cardiomyopathy Genetic test prices

Showing 16–30 of 40 matching tests.

Cardiomyopathy Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4345 LDB3 Gene-Related Dilated Cardiomyopathy Type 1C (DCM-1C) Genetic Test This genetic test evaluates for pathogenic variants in the LDB3 gene associated with autosomal dominant dilated cardiomyopathy type 1C.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in LDB3 gene exons", "Pathogenic variants in LDB3 gene splice-site regions"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed cardiac medications"] Indications ["Diagnosis of DCM-1C", "Risk assessment for family members of DCM-1C patients", "Pre-participation sports screening (Tier 2)"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: I42.0 Clinical summary This genetic test evaluates for pathogenic variants in the LDB3 gene associated with autosomal dominant dilated cardiomyopathy type 1C.
TEST-2542 Maternally Inherited Cardiomyopathy (MICM) Mutation Detection Test This test detects pathogenic variants within the entire mitochondrial DNA sequence associated with maternally inherited cardiomyopathy.	EDTA whole blood (peripheral)	10 working days from sample receipt	1,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mitochondrial DNA mutations", "Pathogenic variants linked to cardiomyopathy"] Parameters [] Preparation [] Indications ["Diagnosis of suspected maternally inherited cardiomyopathy", "Family screening for individuals with a maternal history of cardiomyopathy", "Genetic counseling for reproductive planning in affected families"] Measurement technique Confirm with laboratory Codes LOINC: 83092-7 ICD-10: I42.8, E88.40, Z15.89 Clinical summary This test detects pathogenic variants within the entire mitochondrial DNA sequence associated with maternally inherited cardiomyopathy.
TEST-4262 MT-TH Gene Sequencing for Idiopathic Dilated Mitochondrial Cardiomyopathy (NGS) Test This test identifies pathogenic variants in the MT-TH gene, which can cause mitochondrial dilated cardiomyopathy.	Whole blood (EDTA), FTA card, or extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MT-TH gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Diagnosis of idiopathic dilated cardiomyopathy with suspected mitochondrial inheritance", "Family screening for cardiomyopathy", "Personalized management of heart conditions"] Measurement technique Confirm with laboratory Codes LOINC: 94390-5 ICD-10: I42.0 Clinical summary This test identifies pathogenic variants in the MT-TH gene, which can cause mitochondrial dilated cardiomyopathy.
TEST-4271 MT-TI Gene Cardiomyopathy‑Related Genetic Test This genetic test identifies pathogenic variants in the mitochondrial MT-TI gene associated with maternally inherited cardiomyopathy.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MT-TI gene", "Mitochondrial DNA analysis"] Parameters [] Preparation [] Indications ["Individuals with a family history of maternally inherited cardiomyopathy", "Risk assessment for at-risk family members", "Diagnostic confirmation in suspected cases"] Measurement technique Confirm with laboratory Codes LOINC: 68748-5 ICD-10: I42.8 Clinical summary This genetic test identifies pathogenic variants in the mitochondrial MT-TI gene associated with maternally inherited cardiomyopathy.
TEST-4266 MT‑TG Gene Hypertrophic Cardiomyopathy (MT‑TG‑Related) Genetic Test This test identifies pathogenic variants in the MT‑TG gene linked to hypertrophic cardiomyopathy.	Peripheral Whole Blood (EDTA) or Dried Blood Spot (DBS)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MT‑TG gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory"] Indications ["Diagnosis of hypertrophic cardiomyopathy", "Family cascade screening", "Athletic clearance"] Measurement technique Confirm with laboratory Codes LOINC: 100376-2 ICD-10: I42.1, I42.2 Clinical summary This test identifies pathogenic variants in the MT‑TG gene linked to hypertrophic cardiomyopathy.
TEST-4283 MYBPC3 Gene Cardiomyopathy, Familial Hypertrophic Type 4 Genetic Test This test identifies pathogenic variants in the MYBPC3 gene, a common cause of familial hypertrophic cardiomyopathy.	Whole Blood (Peripheral) – EDTA tube	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYBPC3 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Do not alter prescribed medications"] Indications ["Diagnosis confirmation of familial hypertrophic cardiomyopathy (HCM)", "Family cascade screening for HCM", "Risk assessment for family members", "Guiding cardiac surveillance"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: I42.1 Clinical summary This test identifies pathogenic variants in the MYBPC3 gene, a common cause of familial hypertrophic cardiomyopathy.
TEST-4331 MYH7 Gene Cardiomyopathy (Dilated Type 1S) Genetic Test This genetic test evaluates the MYH7 gene for pathogenic variants linked to dilated cardiomyopathy type 1S.	Peripheral whole blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MYH7 gene coding region", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of all medications"] Indications ["Diagnosis of dilated cardiomyopathy type 1S", "Family risk stratification", "Personalised cardiac management"] Measurement technique Confirm with laboratory Codes LOINC: 81324-7 ICD-10: I42.0 Clinical summary This genetic test evaluates the MYH7 gene for pathogenic variants linked to dilated cardiomyopathy type 1S.
TEST-4275 MYH7 Gene Cardiomyopathy, Familial Hypertrophic Type 1 Genetic Test This test identifies pathogenic variants within the MYH7 gene associated with familial hypertrophic cardiomyopathy type 1.	Whole Blood (Peripheral)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYH7 gene", "Copy number variants (CNVs) in the MYH7 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Diagnosis of familial hypertrophic cardiomyopathy type 1", "Risk assessment for family members of affected individuals", "Cascade screening for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 94246-7 ICD-10: I42.1 Clinical summary This test identifies pathogenic variants within the MYH7 gene associated with familial hypertrophic cardiomyopathy type 1.
TEST-4297 MYL2 Gene Familial Hypertrophic Cardiomyopathy Type 10 Genetic Test This test identifies pathogenic variants in the MYL2 gene associated with familial hypertrophic cardiomyopathy type 10.	Peripheral whole blood (3–5 mL in EDTA tube), extracted DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYL2 gene", "Missense mutations", "Nonsense mutations", "Splice-site mutations", "Small insertions/deletions"] Parameters [] Preparation ["Do not discontinue any prescribed cardiac medication without explicit consultation with your treating physician."] Indications ["Diagnosis of familial hypertrophic cardiomyopathy type 10", "Family screening for MYL2-related cardiomyopathy", "Risk stratification in relatives"] Measurement technique Confirm with laboratory Codes LOINC: 93172-3 ICD-10: I42.1 Clinical summary This test identifies pathogenic variants in the MYL2 gene associated with familial hypertrophic cardiomyopathy type 10.
TEST-4251 MYL3 Gene (Familial Hypertrophic Cardiomyopathy Type 8) Test This genetic test identifies pathogenic variants within the MYL3 gene, which are associated with familial hypertrophic cardiomyopathy type 8.	Whole Blood (EDTA), Extracted DNA, or DNA FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYL3 gene", "Single-nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation [] Indications ["Diagnosis of familial hypertrophic cardiomyopathy type 8", "Risk assessment in family members of affected individuals", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 104207-1 ICD-10: I42.2 Clinical summary This genetic test identifies pathogenic variants within the MYL3 gene, which are associated with familial hypertrophic cardiomyopathy type 8.
TEST-4268 MYOZ2 Gene (Familial Hypertrophic Cardiomyopathy Type 16) Genetic Test This test evaluates the MYOZ2 gene for variants associated with familial hypertrophic cardiomyopathy type 16.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in MYOZ2 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation [] Indications ["Individuals with a clinical diagnosis of hypertrophic cardiomyopathy", "Individuals with a family history of unexplained sudden cardiac death or HCM", "Asymptomatic relatives seeking risk clarification"] Measurement technique Confirm with laboratory Codes LOINC: 93929-0 ICD-10: I42.2 Clinical summary This test evaluates the MYOZ2 gene for variants associated with familial hypertrophic cardiomyopathy type 16.
TEST-4343 MYPN Gene Dilated Cardiomyopathy Type 1KK Genetic Test This test analyzes the MYPN gene for pathogenic variants associated with Dilated Cardiomyopathy Type 1KK.	Peripheral Whole Blood or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MYPN gene coding region variants", "SNVs", "Indels", "CNVs"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed before the test"] Indications ["Diagnosis of Dilated Cardiomyopathy Type 1KK", "Risk assessment for individuals with family history", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 101943-6 ICD-10: I42.0, Z15.89, Z82.41 Clinical summary This test analyzes the MYPN gene for pathogenic variants associated with Dilated Cardiomyopathy Type 1KK.
TEST-4256 PRKAG2 Gene Cardiomyopathy, Familial Hypertrophic Type 6 Genetic Test This genetic test detects mutations in the PRKAG2 gene linked to familial hypertrophic cardiomyopathy type 6.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRKAG2 gene", "Glycogen storage disorder association"] Parameters [] Preparation [] Indications ["Individuals with a personal or family history suggestive of familial hypertrophic cardiomyopathy type 6", "Risk assessment for sudden cardiac death"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: I42.2 Clinical summary This genetic test detects mutations in the PRKAG2 gene linked to familial hypertrophic cardiomyopathy type 6.
TEST-4336 SCN5A Gene Dilated Cardiomyopathy Type 1E Genetic Test This genetic test identifies pathogenic variants in the SCN5A gene associated with Dilated Cardiomyopathy Type 1E.	Peripheral Whole Blood (collected in EDTA tube)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SCN5A gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number variations"] Parameters [] Preparation ["Mandatory genetic counselling session prior to testing"] Indications ["Patients with clinical or imaging evidence of dilated cardiomyopathy", "First-degree relative carrying a known SCN5A pathogenic variant", "Asymptomatic individuals with a high-risk family background"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: I42.0 Clinical summary This genetic test identifies pathogenic variants in the SCN5A gene associated with Dilated Cardiomyopathy Type 1E.
TEST-4319 SGCD Gene Dilated Cardiomyopathy (Type 1L) Genetic Test This test identifies pathogenic variants in the SGCD gene associated with dilated cardiomyopathy type 1L.	Peripheral whole blood (or extracted DNA/FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SGCD gene", "Deletion/Duplication (CNV) analysis of SGCD gene"] Parameters [] Preparation ["No special dietary preparation is needed"] Indications ["Definitive diagnosis of dilated cardiomyopathy type 1L", "Cascade screening in affected families"] Measurement technique Confirm with laboratory Codes LOINC: 81301-7 ICD-10: I42.0 Clinical summary This test identifies pathogenic variants in the SGCD gene associated with dilated cardiomyopathy type 1L.

Category overview

Cardiomyopathy Genetic: overview

Navigating unexplained heart failure or an enlarged heart requires highly specific diagnostic clarity to unlock the most effective, personalized cardiac care. As an advanced offering in our Genetics department, Cardiomyopathy Genetic testing meticulously maps your DNA to identify specific inherited mutations that weaken the heart muscle, such as those causing hypertrophic or dilated cardiomyopathy. By leveraging cutting-edge genomic technology, this crucial preventative screening helps confirm your diagnosis and assess familial risks, providing the definitive data needed to safely guide life-saving cardiovascular management and targeted therapies. Consistently trusted by cardiologists across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, unparalleled diagnostic accuracy, and prompt, reliable turnaround times. Protect your cardiovascular wellness—book your cardiomyopathy genetic testing in UAE, arrange a secure home sample collection, or consult our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.